http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2012131344-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-417 |
| filingDate | 2010-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2014-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2012131344-A |
| titleOfInvention | PURIFIED PYROLOCHINOLINYL-PYROROLIDINE-2,5-DIONIC COMPOSITIONS AND METHODS FOR PRODUCING AND USING THEM |
| abstract | 1. Polymorph (-) - 3- (5,6-dihydro-4H-pyrrolo [3,2,1-] quinolin-1-yl) -4- (1H-indol-3-yl) pyrrolidin-2, 5-dione, characterized by an X-ray powder diffraction pattern that includes peaks in the region of 8.2, 10.8, and 14.1 º2θ when using Cu Kα radiation. 2. The polymorph according to claim 1, characterized by a powder x-ray diffractogram including peaks in the region of 8.2, 10.8, 14.1, 15.5, 17.8, 19.9 and 25.6 º 2θ when using Cu Kα radiation. 3. The polymorph according to claim 1, characterized by a powder x-ray diffractogram, including peaks in the region of 8.2, 10.8, 14.1, 14.9, 15.5, 17.1, 17.8, 19.4, 19, 9, 21.1, 21.9, 23.0, 25.6 and 28.4 º2θ when using Cu Kα radiation. 4. Polymorph (-) - 3- (5,6-dihydro-4H-pyrrolo [3,2,1-ij] quinolin-1-yl) -4- (1H-indol-3-yl) pyrrolidin-2,5 -dione, characterized by a powder X-ray diffraction pattern, including peaks in the region of 6.5, 9.9, and 12 º2θ when using Cu Kα radiation. 5. The polymorph according to claim 4, characterized by a powder X-ray diffractogram including peaks in the region of 6.5, 9.9, 12.0, 16.7, 20.1 and 22.8 º 2θ when using Cu Kα radiation. The polymorph according to claim 4, characterized by a powder x-ray diffractogram, including peaks in the region of about 6.5, 9.9, 12.0, 13.2, 16.4, 16.7, 17.2, 20.1, 20, 3, 20.8, 22.8, 23.7, 28.6 and 30.4 º2θ when using Cu Kα radiation. 7. (±) - 3- (5,6-dihydro-4H-pyrrolo [3,2,1-] quinolin-1-yl) -4- (1H-indol-3-yl) pyrrolidin-2,5-diondichloromethane .eight. A composition comprising (±) - 3- (5,6-dihydro-4H-pyrrolo [3,2,1-] quinolin-1-yl) -4- (1H-indol-3-yl) pyrrolidin-2, 5-diondichloromethane. 9. The composition of claim 8, comprising more than 90% (±) - 3- (5,6-dihydro-4H-pyrrolo [3,2,1-] quinolin-1-yl) -4- (1H-indole- 3-yl) pyrrolidin-2,5-diondichloromethane. 10. The composition of claim 9, comprising more than 95% (±) - 3- (5,6-dihydro-4H-pyrrolo [3,2,1-ij] quin |
| priorityDate | 2009-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 47.